First there was the news of the ratcheting up of COVID vaccine prices that is very likely on the way:
...Moderna’s announcement early this month that it would consider a price hike on the vaccine was inevitable. Pfizer and BioNTech had made a similar announcement last October. But Moderna’s proposed quadrupling of the price—from the current $26 per dose to between $110 and $130 per dose—is a stunning 4,000 percent increase from its manufacturing cost of $2.85 per dose...
Now, word has come, from the UK at least (so far?), that getting a COVID vaccine on the public dime will soon get harder for large swaths of the population:
Booster jabs will no longer be available to healthy under-50s from February 12 - meaning Brits have just 12 days to book a slot.
Offers of first and second doses will also be withdrawn later this year...
...As the transition continues away from a pandemic emergency response towards pandemic recovery, the JCVI has advised that the 2021 booster offer (third dose) for persons aged 16 to 49 years who are not in a clinical risk group should close in alignment with the close of the autumn 2022 booster vaccination campaign...
However...
As we pivot from one type of pandemic response to another it is also worth remembering, as we noted previously, that the rich (and/or Davos Man and Woman) are not like you and me.
OK?
.
.
No comments:
Post a Comment